First Hospital Of China Medical University

This study will test whether an artificial intelligence (AI) system can help community doctors better manage patients who have high blood pressure along with diabetes or high cholesterol. About 6,800 adults will be split into two groups: one where doctors use the AI tool to guide…

This study tests whether a clot-dissolving drug called tenecteplase works better than standard antiplatelet pills for people who have a mild but disabling stroke caused by a large blocked artery. About 864 adults who arrive at the hospital 4.5 to 24 hours after symptoms start wil…

This Phase 2 trial tests a new drug called SHR-A1811, alone or with hormone therapy (letrozole), against standard chemotherapy in 120 women with early-stage HR-positive, HER2-low breast cancer. The goal is to see if these combinations can shrink tumors before surgery more effecti…

This phase II trial is testing whether a combination of two drugs—sacituzumab govitecan (a targeted chemotherapy) and tislelizumab (an immunotherapy)—can effectively treat early-stage triple-negative breast cancer with a less intense approach. The study will enroll 30 people and …

This study will test if combining digital technology (analyzing how people walk, their facial expressions, and speech) with blood markers can better screen for early Alzheimer's disease in community adults aged 50 and older. The goal is to create a more efficient screening method…

This study aims to see if a new heart ultrasound technique, called myocardial work, can predict which patients will respond to cardiac resynchronization therapy (CRT) for heart failure. Researchers will also establish normal heart ultrasound values in healthy Chinese adults. The …

This study will measure a specific heart function index in 2,640 healthy adults and people with heart conditions using AI-enhanced 3D ultrasound. The goal is to establish normal ranges and see how this measurement changes in diseases like heart failure and high blood pressure in …